A Study of Myasthenia Gravis in China
Treatments studied
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study follows people with myasthenia gravis who are patients at Peking Union Medical College Hospital to learn more about the disease and how it affects patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of myasthenia gravis.
- You must have visited the neurology clinic at Peking Union Medical College Hospital (PUMCH) between September 2022 and September 2024.
- You must have been followed at PUMCH for at least 6 months.
- You cannot have another condition that causes muscle weakness and makes it hard to tell your symptoms apart.
- You must be willing to sign a consent form to join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry to collect information about people with myasthenia gravis in China. By joining, you help researchers learn more about the condition and how it affects different people.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
This trial tests an experimental oral medication called NMD670 for people with myasthenia gravis (MG). It aims to see if the drug is safe and if it helps improve muscle strength and daily function.
This trial tests if a traditional Chinese herbal formula, Bu Zhong Yi Qi Tang, can help people with ocular myasthenia gravis. It combines the herbal treatment with standard Western medicine to see if it improves symptoms.
This trial tests multiple treatment combinations for people with myasthenia gravis (MG), a condition that causes muscle weakness. It aims to find safer and more effective options by comparing different therapies.
This study is a patient registry that tracks the experiences of people with myasthenia gravis over time. It aims to better understand the condition and improve care, using a smartphone, tablet, or computer to share information.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.